<DOC>
	<DOCNO>NCT03017222</DOCNO>
	<brief_summary>Patients least two risk factor PONV ( Postoperative nausea vomit ) underwent laparoscopic surgery general anesthesia assess eligibility . Patients develop PONV within first 2 hour anesthesia receive intravenously , randomize double-blind manner , ondansetron 4 mg ramosetron 0.3 mg . Patients observe 24 hour drug administration . The incidence nausea vomiting , severity nausea , requirement rescue antiemetic adverse effect 0-2 2-24 hour drug administration evaluate . The primary endpoint rate patient exhibit complete response , define emesis rescue antiemetic medication 24 hour drug administration .</brief_summary>
	<brief_title>Therapeutic Efficacy Ramosetron Treatment Established PONV After Laparoscopic Surgery</brief_title>
	<detailed_description />
	<mesh_term>Ramosetron</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>age 1965 year patient undergo elective laparoscopic surgery inhalational anesthesia duration surgery 30 min 4 h ASA ( American Society Anesthesiologists ) physical status I II , patient least two risk factor female gender , history motion sickness ( MS ) PONV , nonsmoking , use postoperative opioids . patient history allergic 5HT3 receptor antagonist patient history anticancer chemotherapy chronic opioids use , alcohol abuse , drug abuse patient take antiemetic medication within 24 h surgery , steroid within 24 h surgery 24 h surgery presence renal ( serum Cr &gt; 1.6 mg/dl ) hepatic ( liver enzymes 2 time normal value ) insufficiency patient convert open laparotomy patient pregnant breastfeeding patient borderline QTc ( correct QT interval ) prolongation ( &gt; 430 m male , &gt; 450 ms female ) patient able understand score pain express degree PONV .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>